MedPath

CIPROFLOXACIN

CIPROFLOXACIN TABLETS, USP

Approved
Approval ID

9d04904f-872b-4e1c-9bc7-e012f42ce584

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 25, 2010

Manufacturers
FDA

Blenheim Pharmacal, Inc.

DUNS: 171434587

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ciprofloxacin

PRODUCT DETAILS

NDC Product Code10544-604
Application NumberANDA075593
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateAugust 25, 2010
Generic NameCiprofloxacin

INGREDIENTS (9)

silicon dioxideInactive
Code: ETJ7Z6XBU4
Classification: IACT
magnesium stearateInactive
Code: 70097M6I30
Classification: IACT
Ciprofloxacin hydrochlorideActive
Quantity: 250 mg in 1 1
Code: 4BA73M5E37
Classification: ACTIM
HYPROMELLOSE 2910 (5 CPS)Inactive
Code: R75537T0T4
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
polyethylene glycol 400Inactive
Code: B697894SGQ
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
titanium dioxideInactive
Code: 15FIX9V2JP
Classification: IACT
© Copyright 2025. All Rights Reserved by MedPath
CIPROFLOXACIN - FDA Approval | MedPath